| 000 | 01584 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516101300.0 | ||
| 264 | 0 | _c20120724 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a0890-9016 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInui, Masashi | |
| 245 | 0 | 0 |
_aKidney transplantation at Tokyo Women's Medical University. _h[electronic resource] |
| 260 |
_bClinical transplants _c2011 |
||
| 300 |
_a127-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aABO Blood-Group System _ximmunology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Group Incompatibility _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDesensitization, Immunologic |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHistocompatibility |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aLiving Donors _xsupply & distribution |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue and Organ Procurement |
| 650 | 0 | 4 | _aTokyo |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aIshida, Hideki | |
| 700 | 1 | _aOmoto, Kazuya | |
| 700 | 1 | _aTanabe, Tatsu | |
| 700 | 1 | _aHattori, Motoshi | |
| 700 | 1 | _aHirano, Hajime | |
| 700 | 1 | _aTanabe, Kazunari | |
| 773 | 0 |
_tClinical transplants _gp. 127-43 |
|
| 999 |
_c21914627 _d21914627 |
||